Singapore markets close in 2 hours 3 minutes

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.69-2.36 (-6.93%)
At close: 04:00PM EST
30.24 -1.45 (-4.58%)
After hours: 07:44PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 2.12B
Enterprise value 1.48B
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.47
Enterprise value/revenue 64.18
Enterprise value/EBITDA -5.74

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-41.05%
S&P500 52-week change 3-7.75%
52-week high 365.92
52-week low 313.60
50-day moving average 326.17
200-day moving average 328.31

Share statistics

Avg vol (3-month) 3752.68k
Avg vol (10-day) 3676.18k
Shares outstanding 562.38M
Implied shares outstanding 6N/A
Float 837.98M
% held by insiders 17.54%
% held by institutions 1103.90%
Shares short (12 Jan 2023) 412.48M
Short ratio (12 Jan 2023) 414.23
Short % of float (12 Jan 2023) 430.18%
Short % of shares outstanding (12 Jan 2023) 420.01%
Shares short (prior month 14 Dec 2022) 410.37M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.41%
Return on equity (ttm)-48.06%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -257.36M
Net income avi to common (ttm)-259.31M
Diluted EPS (ttm)-4.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)651.94M
Total cash per share (mrq)10.49
Total debt (mrq)5.73M
Total debt/equity (mrq)0.94
Current ratio (mrq)13.28
Book value per share (mrq)9.86

Cash flow statement

Operating cash flow (ttm)-153.68M
Levered free cash flow (ttm)-82.95M